These findings increase knowledge about Glo2 [51] and open new perspectives for the development of targeted therapies against breast cancer and other cancers that express high levels of Glo2, although further research is needed to investigate the additional role of Glo2 in cancer. The gene discussed is HAGH; the disease is cancer.